





















differentiate	 from	 common	 neural	 progenitor	 cells	 (NPCs). Postnatally, some	 of
these	cells	transform	to	adult	neural	stem/progenitor	cells	which	reside	in	specialized
niches	where	they	continue	to	produce	neurons. The	mechanisms	controlling	NPC
fate, however, are	not	fully	understood. Microarray	analysis	of	ribosome-enriched
transcripts	in	NPCs	revealed	a	preferential	loading	of	ribosomes	with	transcripts	im-
portant	for	neuronal	differentiation. One	preferentially	loaded	transcript	is	Ankyrin
repeat	 and	KH domain-containing	protein 1	 (ANKHD1). ANKHD1	 is	 a	270 kDa
protein	that	has	been	shown	to	play	important	roles	in	progenitor	cell	proliferation,























(NPCs). Einige	NPCs	werden	postnatal	 zu	 adulten	neuralen	 Stamm-	 /	Vorläufer-
zellen, die	sich	in	spezialisierten	Nischen	beﬁnden	und	weiterhin	Neuronen	pro-
duzieren. Die	Mechanismen, die	das	NPC Schicksal	kontrollieren	sind	nicht	voll-
ständig	verstanden. Microarray	Analysen	von	Ribosom-angereicherten	Transkripten
in	NPCs	haben	gezeigt, dass	Ribosomen	bevorzugt	mit	Transkripten	geladen	wer-
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isms, including	mammals. During	development, regulation	of	progenitor	identity,














(see	section 1.4.1). Moreover, in	some	tissues, progenitor	cells	can	react	to	certain
stimuli	(such	as	injury)	and	accordingly	change	their	proliferation	and	differentiation
programs. For	instance, bronchioalveolar	stem	cells	in	the	lung	proliferate	during
epithelial	cell	 renewal	 [46], and	progenitors	 in	 the	brain	can	be	activated	–	and
change	the	fate	of	their	progenies	–	following	insults	such	as	stroke	or	ischemia	(see
Nakafuku M [61] for	reviews). However, also	non-injury	/	 tissue	damage	related
changes	do	occur	in	progenitor	cells. For	instance, increase	of	neuronal	output	after
physical	activity	(running	[96]	and	learning	[32])	has	been	reported. Besides	their
tissue	repair, maintenance, and	other	physiological	functions, stem	/	progenitor	cells
have	been	also	connected	to	disease	development, e.g. in	cancer	(see 1.4.2).
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(i.e. their	cortical	 layers	 form	 folded	structures	as	consequence	of	a	 tremendous
expansion	of	 cell	numbers)	 versus	 the	 lissencephalic	brain	of	mice	are	currently
studied. Nonetheless, many	mechanisms	studied	and	discovered	in	mice	hold	true








followed	by	the	neural	 tube. The	most	anterior	part	of	 the	neural	 tube	forms	the
brain, while	 the	 remaining	 neural	 tube	 develops	 into	 the	 spinal	 column. Three
vesicle-like	structures, the	prosencephalon, mesencephalon, and	rhombencephalon
arise	from	the	most	anterior	part	of	the	neural	tube	at	E10.5	in	mice	and	E28	in	hu-
mans, representing	 the	basic	structures	 from	which	the	brain	develops	[86]. The








including	the	thalamus, subthalamus, hypothalamus	and	epithalamus	[42]. The	te-
lencephalon	on	the	other	hand	develops	into	the	cerebrum, which	consists	of	the
cerebral	cortex, hippocampus, basal	ganglia, and	olfactory	bulbs. Basal	ganglia
mainly	 consist	 of	 (amongst	other	 groups	of	nuclei)	 the	 striatum, globus	pallidus,
substantia	nigra, nucleus	accumbens, and	subthalamic	nucleus.
Within	 the	cerebrum, the	cerebral	 cortex	 forms	 the	neocortex, archicortex	 (Hip-
pocampus)	and	paleocortex. The	neocortex	accounts	for	approximately	three	quar-
ters	of	human	brain	volume	and	is	responsible	for	higher	functions, such	as	con-
scious	thought, language, and	sensory	perception. Evolutionary, it	is	the	newest	part
of	the	cerebral	cortex. It	is	built	up	of	a	six	layered	structure	that	is	lissencephalic










terning	of	 the	 telencephalon. The	main	 signaling	centers	are	 the	anterior	neural
ridge	(later	commisural	plate; ANR/CoP),	the	cortical	hem, the	anti-hem	(or	pallial-
subpallial	boundary	(PSB)) and	the	ventral	signaling	center	(see	Fig. 1 for	an	illus-
tration	of	signaling	centers	and	patterning). The	main	signaling	molecules	include
various	FGF ligands, BMPs	/	Wnt, and	Sonic	Hedgehog	(SHH).	For	instance, FGF8
is	produced	rostrally	in	the	ANR/CoP,	while	BMPs	and	Wnt	are	expressed	caudally
and	dorsally	in	the	cortical	hem. FGF7	and	TGF-a	are	produced	in	the	anti-hem	and




















Morphogens from signaling centers Graded TF expression Prospective area boundaries
A B
Figure 1: Patterning in the telencephalon. Modiﬁed from Iwata and Hevner [41]. Signaling centers
(A) establish transcription factor (TF) gradients (B) which form prospective area boundaries. ANR/CoP
= anterior neural ridge / commisural plate; Shh = Sonic Hedgehog; A = anterior; P = posterior; D =






















rons	ﬁrst, at	later	stages	astrocytes	and	even	later	stages	oligodendrocytes. Figure 2
shows	a	schematic	representation	of	the	temporary	distinct, yet	overlapping, phases
of	 neuronal	 and	 glial	 differentiation	 in	 the	mammalian	 neocortex. During	 each
asymmetric	division	a	RG cell	produces	a	new	RG cell	 (i.e. self	 renewal)	and	a
neuron	or	basal	progenitor	(BP) cell3, which	can	further	divide	symmetrically	be-
fore	ﬁnal	differentiation	(Figure 3 illustrates	symmetric	and	asymmetric	divisions	of
RG and	BPs	during	neocortical	development). In	this	way, RG can	specify	during
neocortical	development	to	produce	all	the	different	neuronal	subtypes, astrocytes,
and	oligodendrocytes. While	fate-mapping	and	clonal	experiments in	vitro and in




fate	potential. For	instance, Franco	et al. [28] identiﬁed	Cux2	positive	RG cells	in
the	developing	murine	neocortex	that	are	intrinsically	speciﬁed	to	only	give	rise	to










process	[36, 55, 66]. They	are	rarely	found	in	mice, but	more	abundant	in	ferret





E8 E10 E11 E12 E13 E15 E16E14 E17 E19E18 E20 P1 P7P3 P9P5 P11 P13 P15 P17
Figure 2: Timing of neuronal and glial development in the neocortex. Modiﬁed from Sauvageot
and Stiles [75]. The waves of subsequent generation of neurons, astrocytes, and oligodendrocytes
are illustrated in correlation to the time of embryonic (E8 – E20 [=birth]) and post-natal (P1 – P17)
development.
Early	 in	cortical	development, asymmetrical	divisions	of	RG lead	 to	self	 renewal
and	generation	of	a	post	mitotic	neuron. Throughout	the	majority	of	neocortical	de-





















































Neuroepithelium Embryonic Neonatal AdultBirth
Figure 1
Glial nature of neural stem cells (NSCs) in development and in the adult. Neuroepithelial cells in early development divide
symmetrically to generate more neuroepithelial cells. Some neuroepithelial cells likely generate early neurons. As the developing brain
epithelium thickens, neuroepithelial cells elongate and convert into radial glial (RG) cells. RG divide asymmetrically to generate
neurons directly or indirectly through intermediate progenitor cells (nIPCs). Oligodendrocytes are also derived from RG through
intermediate progenitor cells that generate oligodendrocytes (oIPCs). As the progeny from RG and IPCs move into the mantel for
differentiation, the brain thickness, further elongating RG cells. Radial glia have apical-basal polarity: apically (down), RG contact the
ventricle, where they project a single primary cilium; basally (up), RG contact the meninges, basal lamina, and blood vessels. At the end
of embryonic development, most RG begin to detach from the apical side and convert into astrocytes while oIPC production continues.
Production of astrocytes may also include some IPCs (see Figure 2) not illustrated here. A subpopulation of RG retain apical contact
and continue functioning as NSCs in the neonate. These neonatal RG continue to generate neurons and oligodendrocytes through
nIPCs and oIPCS; some convert into ependymal cells, whereas others convert into adult SVZ astrocytes (type B cells) that continue to
function as NSCs in the adult. B cells maintain an epithelial organization with apical contact at the ventricle and basal endings in blood
vessels. B cells continue to generate neurons and oligodendrocytes through (n and o) IPCs. This illustration depicts some of what is
known for the developing and adult rodent brain. Timing and number of divisions likely vary from one species to another, but the
general principles of NSC identity and lineages are likely to be preserved. Solid arrows are supported by experimental evidence; dashed
arrows are hypothetical. Colors depict symmetric, asymmetric, or direct transformation. IPC, intermediate progenitor cell;
MA, mantle; MZ, marginal zone; NE, neuroepithelium; nIPC, neurogenic progenitor cell; oIPC, oligodendrocytic progenitor cell;
RG, radial glia; SVZ, subventricular zone; VZ, ventricular zone.
(IPCs). IPCs can generate neurons (nIPCs) or
generate glial cells, including oligodendrocytes
(oIPCs) or astrocytes (aIPCs) (Figure 1). The
termglial cell becomes somewhat confusing be-
cause it refers to both a progenitor population as
well as a differentiated population of parenchy-
mal astrocytes, oligodendrocytes, and ependy-
mal cells (as discussed below, this problem also
applies to the term astrocyte). However, at least
some of the functions attributed to terminally
differentiated astrocytes (supporting neuronal










likely represented in the adult and earlier pro-
genitor cells including RG. Short of proposing
an entirely new nomenclature, which could add
confusion, we use the term glia more generally
to refer both to glial cells that have specialized
traditional glial functions and to those that, in
addition, retain progenitor capacity.
Many recent publications have described
molecular pathways that regulate ventricular
zone (VZ) and subventricular zone (SVZ)
progenitors as well as progress characterizing
NSCs in vitro. Here we mention some of this









































































Figure 3: Modes of division of NPCs duri g eocortical d velopment. Tak n from Kriegstein and
Alvar z-Buylla [48]. RG can divide symmetrically (red arrows) and asymmetrically (blue arrows), while
other progenitors only divide symmetrically. NE = neuroepithelium; MZ = marginal zone; VZ = ven-
tricular zone; SVZ = subventricular zone; MA = mantle zone; oIPC = oligodendrocyte intermediate
prog nitor cell; nIPC = neuronal intermediate progenitor cell.
s	developme t	proceeds. While	RGs	of	the	early	d veloping	brain	are	able	t 	pro-
du e	early	a d	late	born	neurons	(see	below), RGs	of	later	stages	c n	only	generate





and	differ tiate	to	Cajal-R tzius	an 	subpl te	neurons	(SPN).	Following	waves	of
migrating	neurons	then	split	the	preplate	into	the	marginal	zone	and	subplate. Cajal-
Retzius	cells	 form	the	outer	most	neuronal	 layer	during	development	and	are	re-
qui d	for	pr per	positioni g	 f	the	following	waves	of	neu ons	i 	the	c rtical	plate
(CP).	The	six	layers	of	the	CP (layer I –	VI) are	formed	in	an	inside-out	manner, i.e.
newly	differentiating	neurons	migrate	through	already	established	layers	to	form	new
ones	on	top. Hence, layer	VI neurons	are	early	born, while	layer	II/III neurons	are
late	born. Figure 4 illustrates	 the	development	of	 the	neocortex	with	 its	six	neu-

















from	distinct	 locations	 in	 the	subpallium: First, around	E11.5	 in	 the	mouse, tan-
gentially	migrating	cells	origin	from	the	medial	ganglionic	eminences	(MGE) and
the	anterior	entopeduncular	area	(AEP).	They	migrate	superﬁcially	to	the	striatum
and	 invade	 the	cortical	marginal	zone	and	subplate	 [56]. At	E12.5	–	E14.5, the
MGE seems	to	be	the	principle	source	of	these	cells, and	now	a	superﬁcial, as	well
as	a	deep	(i.e. closer	to	the	ventricle)	route	is	used	by	migrating	cells	to	populate
both	the	SVZ /	lower	intermediate	zone	(IZ) and	the	subplate. Later, around	E14.5	–
E16.5, cells	that	migrate	tangentially	into	the	neocortex	seem	to	derive	from	both	the





































E10.5 E11.5 E12.5 E13.5 E14.5
CPN
E15.5
begin to differentiate into radial glia, establishing the 
ventricular zone (VZ)15. Radial glia, in turn, give rise to 
additional progenitor classes, including outer radial glia 
and intermediate progenitors, which together form the 
subventricular zone (SVZ)16,17.
Each of these progenitor populations has distinct 
morphological properties and follows a specific pattern 
of cell division. Radial glia span the thickness of the 
cortex, from the ventricular (apical) surface to the pial 
(basal) surface, and are used as a scaffold by newly born 
neurons as they migrate into the cortex18. They primar-
ily divide asymmetrically to self-renew, while also giv-
ing rise to outer radial glia, intermediate progenitors 
or neurons19,20. Outer radial glia are also unipolar but 
Figure 1 | Neocortical projection neurons are generated in an ‘inside-out’ fashion by diverse progenitor types in the 
VZ and SVZ. This schematic depicts the sequential generation of neocortical projection neuron subtypes and their 
migration to appropriate layers over the course of mouse embryonic development. a | Radial glia (RG) in the ventricular 
zone (VZ) begin to produce projection neurons around embryonic day 11.5 (E11.5). At the same time, RG generate 
intermediate progenitors (IPs) and outer RG (oRG), which establish the subventricular zone (SVZ) and act as 
transit-amplifying cells to increase neuronal production. After neurogenesis is complete, neural progenitors transition to a 
gliogenic mode, generating astrocytes and oligodendrocytes (not shown). Cajal–Retzius (CR) cells primarily migrate into 
neocortical layer I from non-cortical locations, whereas other projection neurons are born in the neocortical VZ and/or 
SVZ and migrate along radial glial processes to reach their final laminar destinations. b | Distinct projection neuron 
subtypes are born in sequential waves over the course of neurogenesis. The peak birth of subplate neurons (SPN) occurs 
around E11.5, with the peak birth of corticothalamic projection neurons (CThPN) and subcerebral projection neurons 
(SCPN) occurring at E12.5 and E13.5, respectively. Layer IV granular neurons (GN) are born around E14.5. Some callosal 
projection neurons (CPN) are born starting at E12.5, and those CPN born concurrently with CThPN and SCPN also migrate 
to deep layers. Most CPN are born between E14.5 and E16.5, and these late-born CPN migrate to superficial cortical 
layers. Peak sizes are proportional to the approximate number of neurons of each subtype born on each day. NE, 
neuroepithelial cell.
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Figure 4: Neuronal subtype development in the neocortex. Modiﬁed from Greig et al. [33]. Timed
generation of neuronal subtypes by radial glia (RG) and intermediate progenitors (IP) (a). Illustration of
main production phas s of various neuro s (b). C = Cajal Retzius c lls, NE = neuroepethelial cells,
RG = radial glia cells, oRG = outer radial glia cells, IP = intermediate progenitor (basal progenitor),
SPN = sub plate neuron, CThPN = corticothalamic projection neur n, SCPN = subcerebral projection




mouse. They	are	produced	by	Nkx2.1+ precursor	cells	in	the	VZ of	the	medial	gan-
glionic	eminences	(MGE) in	the	ventral	telencephalon	and	migrate	tangentially	into
the	neocortex, similar	to	GABAergic	neurons. Later, after	E18, Emx1+ precursors,
presumably	in	the	dorsal	cortex	itself, produce	another	wave	of	oligodendrocytes.
Interestingly, most	of	the	early	born	oligodendrocytes	die	after	birth, leaving	mainly
Emx1	derived	cells	in	the	adult	brain. Apart	from	neurons, astrocytes, and	oligoden-
drocytes, RGs	will	differentiate	to	ependymal	cells	which	are	lining	the	ventricles















include	epidermal	growth	 factor	 (EGF),	platelet-derived	growth	 factor	 (PDGF),	as








[54]. In	mammals	 there	are	 four	receptors	 (Notch1–4), and	ﬁve	classical	 ligands
(Delta-like1, 3, 4	and	 Jagged1, 2), all	of	which	are	 transmembrane	proteins	 that
permit	signaling	between	adjacent	cells	through	direct	contact. Upon	activation	of
the	Notch	receptor	a	series	of	proteolytic	events	eventually	release	the	intracellu-
lar	domain, allowing	it	to	translocate	to	the	nucleus	[54]. There, it	associates	with
transcriptional	co-regulators, such	as	CBF1/RBPjκ and	mastermind, to	activate	gene
transcription. Target	genes	of	Notch	signaling	in	the	vertebrate	nervous	system	are
mainly	 the	basic	helix-loop-helix	 (bHLH) transcriptional	 repressors	hairy	and	en-
hancer	of	split	 (HES) and	HES related	 (HESR/HEY) family	genes	 (especially	Hes 1
and	Hes 5)	[54].
Basic	helix-loop-helix	transcription	factors	(bHLH TFs)	are	important	regulators	of
brain	 development. Apart	 from	 the	 aforementioned	 repressor-type	bHLH genes,
a	 plethora	 of	 proneuronal	 bHLH TFs, including	Neurogenin 1	 and	 2	 (Ngn1, 2),
Achaete	scute-like	1	(Ascl1	/	Mash1), atonal	homolog	1	(Atoh1	/	Math1), and	hairy














Stat)	gliogenic	signaling	[16]. As	mentioned	above, many	bHLH factors	are	regu-













hibiting	gp130-JAK-STAT signaling, respectively. In	SHP2-deﬁcient	mice, the	num-
ber	of	cells	positive	for	the	neuronal	marker	TuJI are	reduced, and	an	increased	in
the	number	of	cells	positive	for	the	astrocytic	marker	GFAP was	observed	[45]. Ke




Their	activity	in	the	adult	brain, however, varies	signiﬁcantly	between	species. For
instance, birds	retain	RG like	cells	in	their	ventricular	zones, and	these	cells	prolif-
erate	and	constantly	add	new	neurons	throughout	most	of	the	telencephalon	[5]. In
poikilotherms, widespread	adult	neurogenesis	persists	and	is	associated	with	con-
stant	brain	growth	[31]. In	most	animals	studied	to	this	day, however, the	majority	of
NPCs	are	lost	at	the	end	of	development, and	neurogenesis	in	the	adult	is	restricted















adult	neurogenesis	 in	humans	stems	from	work	by	Eriksson	et al. [25] in	the	late
1990s.
In	the	adult	brain	of	mammals, neurogenesis	persists	in	two	regions: the	subven-






SVZ are	heterogeneous: According	to	their	location	in	the	SVZ they	are	restricted






In	the	DG of	the	hippocampus, NPCs	give	rise	to	neurons	and	astrocytes, but	only






and	Song [60], and	Bonaguidi	et al. [7]). Adult	neurogenesis	in	the	DG has	been
13





adult	NPCs. Extrinsic	signals, however, can	differ	signiﬁcantly	due	to	the	changed
environment	compared	to	the	embryonic	situation. Some	of	the	conserved	path-
ways	include	Notch, Wnts, BMPs, and	SHH signaling. Transcription	factors	such












Until	 recent	years	 (the	 late	2000s)	 somatic	mutations	 in	differentiated	cells	were
predominantly	perceived	as	the	origin	of	gliomas. However, in	recent	years, more
and	more	evidence	suggests	that	neural	stem	/	progenitor	cells	might	be	the	cells




tumor. For	instance, an	oncogenic	hit	may	occur	in	a	stem	cell, but	only	a	certain,
more	differentiated	progenitor	might	have	the	ability	to	transform	to	a	tumor. in-
deed, using	lineage	tracing	by	MADM,	Liu	et al. [53] have	provided	evidence	for
14
this	theories: They	demonstrated	that	(i)	oncogenic	hits	in	progenitor	cells	are	re-
quired	for	 tumor	initiation, and	(ii)	only	OPCs	(that	either	acquire	 the	oncogenic
mutations	themselves	or	inherit	them	from	aNPCs)	can	form	gliomas	in	a	p53	/	Nf1
mouse	model.
As	a	complementary in	vitro approach	 to	assess	stem	cell	 features, NPCs	can	be
grown	in	so	called	”neurospheres”	in	serum-free	media	supplemented	with	growth








ANKHD1	 is	 a	 recently	discovered	protein	with	 important	 functions	 in	organ	de-
velopment	 and	 tumor	biology. The	protein	was	ﬁrst	described	 in	Drosophila	by
Smith	et al. [84], where	the	homolog	multiple	ankyrin	repeats	and	single	KH domain
(MASK) has	been	found	to	be	an	important	signaling	component	in	photoreceptor
differentiation. One	year	later, the	ﬁrst	study	describing	ANKHD1	in	human	cells
was	published	by	Poulin	et al. [65]. The	following	sections	will	give	an	introduc-






1.5.1 Discovery, sequence	properties, and	structural	features





mask gene. The	genomic	locus	of mask spans	18kb	and	encodes	for	a	protein	of

























The	K homology	(KH) domain was	ﬁrst	discovered	in	–	and	named	after	–	the	het-
erogeneous	nuclear	ribonucleoprotein	(hnRNP) K by	Siomi	et al. [83] in	1993. The
motif	is	a	conserved	sequence	of	around	70	amino	acids. The	KH domain	can	bind





of	KH domains	have	been	described	[34]: Type I domains	form	a	beta-alpha-alpha-
beta-beta-alpha	structure, while	 type II domains	consist	of	alpha-beta-beta-alpha-
alpha-beta	modules. All	beta	strands	run	anitparallel	in	type I domains, while	two
beta-strands	run	parallel	in	type II domains. Type I KH domains	are	usually	found	in
eukaryotes, while	type II domains	are	mostly	found	in	prokaryotes	[95]. The	binding
occurs	in	a	cleft	formed	between	alpha	helix	1, alpha	helix	2, the	highly	conserved
GXXG loop, and	a	variable	 loop. The	binding	cleft	can	only	accommodate	 four
bases	of	the	binding	nucleotide. Proteins	often	contain	multiple	KH motifs, which
can	 function	 independently	or	cooperatively	 [95]. However, some	proteins	only
contain	a	single	KH domain, including	Mer1p, Sam68, and	ANKHD1. Fragile	X
mental	retardation	protein	(FMRP) contains	two	KH domains, and	loss	of	function
mutations	therein	have	been	associated	with	the	fragile	X mental	retardation	syn-
drome	[51].
In	addition	to	the	ANK and	KH domains, MASK contains	several	long	stretches	of
glutamine	residues	and	a	highly	basic	region. MASK does	not	show	signiﬁcant	ho-
mology	in	sequence	or	overall	structure	to	any	protein	of	known	function	[84].







a	8139 bp	long	mRNA (consisting	of	a	5’-UTR of	60	bp, an	ORF of	7629	bp, and
a	3’-UTR of	450-bp)	 [65]	and	produces	a	protein	of	2542	amino	acids	 in	 length
(mouse: 2548 aa). A schematic	illustration	of	human	full	length	ANKHD1	is	shown
in	Fig. 5.
Several	splice	variants	and	isoforms	of	ANKHD1	have	been	described	or	annotated
in	protein	databases. Poulin	et al. [65] actually	ﬁrst	discovered	an	interesting	vari-
ant	 of	ANKHD1, while	working	on	4E-BP3, a	protein	 important	 for	 translational
17






Figure 5: The human ANKHD1 protein. Ankyrin repeats and KH domain are drawn in dark grey in
correct proportion the complete sequence. Numbers indicate amino acid positions.
control, and	located	just	downstream	of	the Ankhd1 genomic	locus. The	authors
showed	that	ANKHD1	and	4E-BP3	loci	can	produce	a	single, approximately	8.5 kb















ANKHD1	paralogs. One	gene, Ankrd17, has	been	identiﬁed	as	paralog	of	ANKHD1
[65, 99]. Ankrd17, also	known	as	gene	trap	ankyrin	repeat	(GTAR) [38]	and	some-
times	referred	to	as	MASK2	[74, 81], shows	71%	homology	to	ANKHD1, and	seem-
ingly	arose	by	gene	duplication	of	ANKHD1[65]. Ankrd17	has	been	shown	to	be
important	for	liver	development	as	well	as	differentiation	of	hematopoeitic	progen-





experiments	yet. So	far, ANKHD1	mRNA expression	was	reported	in	several	mam-
malian	tissues, including	the	mouse	brain	[65]. Data	from	microarray	analyses	of
differentiating	aNPCs	suggests	that	ANKHD1	might	be	expressed	in	these	cells	and
regulated	during	 their	differentiation	 (unpublished	data	 from	our	 lab). Moreover,
the	protein	has	been	detected	in	some	human	tissues	and	cell	 lines	(see	sections










and	survival. The	mutagenesis	screen	in	which mask was	identiﬁed	was	designed
to	reveal	novel	components	of	receptor	tyrosine	kinase	(RTK) signaling	[84]. The






mask resulted	in	smaller	wings	[74, 81]. Moreover, both	studies	showed	that	MASK
is	a	co-factor	of, and	interacts	with, YAP,	a	signaling	component	of	the	Hippo	path-
way	important	 for	 tissue	growth. This	 interaction	was	conﬁrmed	in	human	293T
cells. However, only	Sidor	et al. [81] could	observe	translocation	of	ANKHD1	to
the	nucleus	and	DNA binding, and	 thus	a	 function	as	nuclear	co-factor	 remains









man	 ortholog	 to	Drosophila	CSW,	 the	 nonreceptor	 protein-tyrosine	 phosphatase
SHP2, was	shown	to	be	involved	in	many	leukemias	and	to	be	overexpressed	in
many	 primary	 leukemia	 cells	 and	 in	 leukemia	 cell	 lines. Given	 the	 interaction
of	CWS and	MASK in	Drosophila, Traina	et al. [92] investigated	a	possible	inter-
action	of	SHP2	and	ANKHD1. They	successfully	co-immunoprecipitated	the	two
proteins	in	K562	and	LNCaP cells. The	functional	relevance	of	this	interaction	in














ANKHD1	seems	 to	be	 important	 for	 the	 regulation	of	progenitor	cells	 in	various






ral	 development	 and	 in	 adult	NPCs. First, we	will	 investigate	 the	 expression	of
ANKHD1	in	embryonic	and	adult	NPCs, as	expression	of	ANKHD1	in	NPCs	has
not	been	proven	hitherto. Unpublished	microarray	data	from	our	work	already	sug-





in	 the	 developing	 embryo	 brain in	 vivo. After	 knockdown	 or	 overexpression	 of





































































































PBS,	20x Dissolve	160 g/l	NaCl, 23 g/l Na2HPO4, 28.84 g/l NaH2PO4, 4 g/l	 KCl,
4 g/l KH2PO4 in H2O. Adjust	pH to	7.4	with	HCl.
0.2M monobasic	stock	solution Dissolve	27,8 g/l NaH2PO4 in H2O.
0.2M dibasic	stock	solution Dissolve	107,30 g/l Na2HPO4·7H2O in H2O.
0.2M Phosphate	buffer Combine	69ml	of	0.2M monobasic	 and	231ml	of	0.2M
dibasic	stock	solutions	and	adjust	volume	to	300ml	(pH7.3)	with H2O.
aNPC /	GIC medium Neurobasal A Medium	supplemented	with	B27	Supplement
(1x), L-Glutamine	(2mM),	Penicillin/Streptomycin	(Pen: 100	units/ml; Strep:
100 µg/ml), Heparin	(2 µg/ml), bFGF (20 ng/ml), and	EGF (20 ng/ml).
PDD-Solution Papain	(0.01%), Dispase	2	(0.1%), DNAse	(0.01%), MgSO4	(12.4mM)
in	HBSS (without MgCl2 and CaCl). The	solution	is	sterile	ﬁltered	and	stored
in	aliquots	at	-20°C.
cell	lysis	buffer 25mM Tris·HCl	pH8.0, 0.5mM EDTA,	0.5%	Triton	X-100, 150mM
NaCl, 1mM DTT and	1×Complete	Protease	Inhbitor	Cocktail
IP wash	buffer 25mM TRIS pH7.8, 200mM NaCl, 0.5%	Triton	X-100
PBS-Tween 0.1%Tween-20	in	PBS.
25
Sample	Buffer 125mM Tris-HCl	(pH7.4), glycine	(200ml/l),
-mercaptoethanol	(100ml/l), SDS (40 g/l), brome	phenol	blue	(50mg/l).
Running	Buffer Tris	base	(10 g/l), glycine	(30.28 g/l), SDS (150 g/l)
Transfer	Buffer Tris	base	(3 g/l), glycine	(14.4 g/l), methanol	(200ml/l)
Lower	Tris	Buffer	(4x) Tris	base	(181 g/l), SDS (4 g/l), 37%	HCl	(135ml/l)
Upper	Tris	Buffer	(4x) Tris	base	(60.6 g/l), SDS (4 g/l)
Running	Gel	(per	10ml) 3.5ml H2O, 2.5ml	Lower	Tris	Buffer, 4ml	of	30%	Acry-
lamide, 10 µl	TEMED,	100 µl	of	10%	APS
Stacking	Gel	(per	10ml) 6.35ml H2O, 2.5ml	Upper	Tris	 Buffer, 1.15ml	of	30%
Acrylamide, 10 µl	TEMED,	100 µl	of	10%	APS
Stripping	Buffer 75mMTris-HCl	(pH6.8), SDS (12 g/l), -mercaptoethanol	(4.68ml/l)
HBS 150mM NaCl, 20mM HEPES,	pH7.4
blocking	solution 5%	normal	donkey	serum	, 0.1%	Triton	X-100, 0.5mg/ml	bovine
serum	albumin	in	HBS.
hybridization	buffer Torula	yeast	tqRNA (1mg/ml), Formamid	(50%), 1x	salt	buffer,
10%	dextran	sulphate	solution, 1x	Denhardts	solution. Mix	in	respective	order
and	adjust	volume	with H2O. Store	at	-20ºC.
10x	salt	buffer 114 g/l	NaCl, 14.04 g/l	Tris	HCl, 1.34 g/l	Tris	Base,
7.8 g/l Na2HPO4•2H2O,7.1 g/l NaH2PO4, 18.61 g/l	EDTA.	Dissolve	in H2O.
100x	Denhardts	solution 20mg/ml	BSA,	20mg/ml	Ficoll, 20mg/ml	polyvinylpyrol-
lidone. Dissolve	in H2O and	store	at	-20ºC.
Dextrane	sulfate	solution Dissolve	0.5 g/ml	in H2O, store	at	4ºC.
ISH wash	solution 1xSSc, 50%	form	amide, 0.1%	Tween20	in	water.
5x	MAB buffer 58 g/l	maleic	acid, 43.5 g/l	NcCl, 38.5 g/l	NaOH in	water. Adjust
pH to	7.5	and	ﬁlter	sterile.
MABT buffer Dilute	5x	MAB buffer	to	1x	and	add	0.1%	Tween20.
2%	DIG-blocking	reagent Dissolve	4 g	DIG-block	in	200ml	MABT (heating	required).
Aliquot	and	store	at	-20ºC.
26
ISH staining	buffer 100mM NaCl, 50mM MgCl2, 100mM Tris	pH9.5,
0.1%	Tween20, and	1mM (appr.) Levamisol	in	water	(prepare	fresh).
FP buffer 5%	FCS in	PBS.











YFP (removing	the	stop	codon)	in	the	pCAG-YFP plasmid. This	new	site	(MCS2)	con-



















pFlag-CMV-D11 gateway	destination	vector	with	N-terminal	Flag	tag, DKFZ repository
pFlag-ANKHD1 human	ANKHD1	cloned	into	pFlag-CMV-D11
pFlag-ANKHD1-∆C truncated	ANKHD1	on	C-terminus, KH domain	missing
pYFP-ANKHD1 human	ANKHD1	cloned	into	pCAG-YFP,	generating	YFP tagged	protein
2.1.4 Antibodies
Primary	and	secondary	antibodies	are	described	in	table 4 and 5, respectively.
Table 4: Primary antibodies
Name Species Clonality Manufacturer Concentration
Actin goat polyclonal Santa	Cruz 1:5000	(WB)
Akt rabbit polyclonal Cell	signaling 1:1000	(WB)
Ankhd1 rabbit polyclonal Sigma 1:1000	(WB),	1:200	(IP)
Erk rabbit polyclonal Santa	Cruz 1:1000	(WB)
Flag mouse monoclonal Sigma 1:1000	(WB)
GAPDH mouse monoclonal Santa	Cruz 1:1000	(WB)
GFP chicken monoclonal Aves 1:1000	(WB),	1:200	(IP)
p21 mouse monoclonal Cell	Signaling 1:500	(WB)
pAkt rabbit polyclonal Cell	signaling 1:1000	(WB)
pErk rabbit polyclonal Santa	Cruz 1:1000	(WB)
Satb2 mouse monoclonal Abcam 1:200	(IF)
Tbr2 rabbit polyclonal Abcam 1:500	(IF)





donkey	anti	goat	HRP conj. Santa	Cruz 1:5000	(WB)
goat	anti	mouse	HRP conj. Dianova 1:5000	(WB)












glucose), supplemented	with	10%	fetal	bovine	serum, 2mM Glutamine	and	antibi-





riﬁced	and	 tissue	 from	 the	 SVZ was	dissected	 into	 ice-cold	HBSS supplemented
with	1%	Penicillin-Streptomycin. Tissue	was	cut	in	small	pieces	with	a	scalpel	and
washed	three	times	with	HBSS/Pen/Strep. Subsequently	tissue	was	digested	in	PDD-
solution	at	room	temperature	 for	30	minutes. After	digestion, cells	were	washed
three	times	in	DMEM/F12	(50%	DMEM,	50%	Ham’s	F12, and	1%	L-Glutamine)	and
subsequently	triturated	using	ﬂame-polished	Pasteur	pipettes. Cells	were	afterwards




morspheres)	in	aNPC/GIC medium. Cell	were	grown	in	25 cm2 or	75 cm2 ﬂasks	at
29
37°C and	5% CO2. For	experiments	with	human	recombinant	CD95L (T4)	treat-





System. Prior	 to	electroporation, neurospheres	or	 tumorpsheres	were	dissociated
into	single	cells, counted, resuspended	in	R buffer	 to	a	cell	density	of	0.5-1x106
cells/100 µl, and	mixed	with	 siRNA or	plasmid	DNA.	We	used	ON-TARGETplus
SMARTpool	siRNAs	from	Thermo	Scientiﬁc. Each	pool	consists	of	four	siRNAs	tar-
geting	either	human ANKHD1 or	non-targeting	sequences. The	speciﬁc	sequences




try. The	siRNA was	used	at	a	concentration	of	0.5 µM,	and	plasmids	at	1 µg	/	100 µl




















In	utero electroporation	was	carried	out	as	described	by	Saito [72]. Brieﬂy, timed
pregnant	C57BL/6	wild	type	mice	were	anesthetized	with	3%	isoﬂuoran	/	1.5	vol%
O2, and	anesthesia	was	maintained	with	0.5	-	1.5%	isoﬂuoran	/	1.5	vol% O2/min.









If	embryos	were	used	for	analysis	24	or	48	hours	post in	utero electroporation, dams
were	sacriﬁced	and	embryos	dissected	from	uterine	horns, yolk	sac, and	amnionic
sac, followed	by	decapitation. Embryo	heads	were	transferred	into	ice	cold	PBS and
subjected	to	ﬁxation	and	cryo-protection	(see 2.2.6), or	dissection	of	cortical	tissue
(see 2.2.5). For	studying	post	natal	pups, dams	were	allowed	to	give	birth	(day	P0)
and	pups	were	 sacriﬁced	at	P2	by	decapitation, without	prior	perfusion. Heads
were	then	ﬁxed	in	4%	PFA solution	over	night	before	subjected	to	cryopreservation,












200 µl	pipette. Samples	were	then	subjected	to	sorting	for	YFP positive	cells	with	a




tion	for	four	hours. PFA was	rinsed	twice	with	PBS before	incubation	in	30%	sucrose
/	PBS overnight	or	until	heads	sunk	to	the	bottom	of	the	well. Heads	were	then	shortly
put	in	OCT solution, before	placement	on	specimen	disks	and	fast	freezing	in	the























SFP buffer, and	incubated	with	secondary	antibodies	for	30	minutes	on	ice. Finally,
cells	were	washed	twice	with	FP buffer	and	resuspendend	in	200 µl	FP buffer	for	ﬂow
cytometry. Fluorescence	data	were	obtained	with	a	FACSCanto II (BD Biosciences)
and	analyzed	using	FlowJo	software.
2.2.9 In	situ hybridization
In	situ hybridization	was	performed	with	DIG labeled	probes	as	follows. ANKHD1
sense	and	antisense	riboprobes	were	DIG labeled	by in	vitrotranscription	of	cDNA












chamber	at	68ºC over	night. The	next	day, slides	were	washed	with	pre-warmed
(68ºC) ISH wash	 solution	 for	 three	 times	 30	minutes, followed	by	 two	 times	 30
minutes	washes	with	MABT buffer, all	shaking. Section	were	blocked	with	DIG-
blocking	reagent	for	one	hour	at	room	temperature, followed	by	anti-DIG antibody
(1:2000	in	DIG-blocking	reagent)	incubation	for	four	hours	at	room	temperature, or







life	technologies. EdU was	added	to	cultured	cells	at	a	ﬁnal	concentration	of	20 µM
for	 the	 indicated	 time, or	 injected	 intraperitoneally	 (1mg)	 into	dams	 for	45	min-
utes. Cells	were	then	ﬁxed	and	subjected	to	EdU detection	and	antibody	staining
according	 to	 the	manufacturer’s	 instructions. Brieﬂy, cells	were	ﬁxed	 for	15	min
with	4%	PFA and	permeabilized	for	30	minutes	at	room	temperature	in	 the	dark
using	a	saponin	based	permeabilisation	solution. Cells	were	then	stained	with	anti-










To	 isolate	RNA from	 tissues, we	used	 the	mirVana™	miRNA Extraction	Kit	with
some	modiﬁcations. Tissue	was	transferred	from	RNAlater	into	300 µl	Lysis/Binding
Buffer	and	homogenized	on	ice	with	a	30G syringe. 30 µl	microRNA homogenate
additive	was	added, the	sample	was	shortly	mixed, and	incubated	for	10	minutes
on	ice. 330 µl	of	acid-phenol:chloroform	was	added, samples	were	mixed	for	one
minute	and	centrifuged	at	13000 rpm	 for	15	minutes	at	4ºC.	The	upper	aqueous
phase	was	 transferred	into	a	 fresh	 tube	and	1.25	volumes	of	100%	ethanol	were
added. Solutions	were	then	applied	onto	spin	columns	and	centrifuged	for	15	sec-
onds	at	10000 rpm. Columns	were	washed	with	350 µl	microRNA Wash	Solution
1. DNA digestion	was	performed	by	adding	80 µl	digestion	mix	(10 µl	DNAse	and
34
70 µl	RDD buffer)	onto	the	column	and	incubation	for	15	minutes	at	room	temper-
ature. Columns	were	again	washed	with	350 µl	microRNA Wash	Solution	1. Next,









20 µl	DEPC-water. RNA quality	and	quantity	was	assessed	with	a	Nanodrop	2000.
Total	mRNA from	cells	was	extracted	by	using	the	RNAeasy	Plus	Mini	Kit	from	Qi-
agen	according	 to	 the	manufacturer’s	 instructions. The	concentration	and	purity
(A260/280	ratios)	was	analyzed	with	a	Nanodrop	2000.
2.2.13 Quantitative	real	time	PCR (qRT-PCR)
Reverse	 transcription	reaction	was	performed	using	 the	Superscript III First	Strand
Synthesis	 SuperMix	 from	 Invitrogen	according	 to	 the	manufacturer’s	 instructions.
Brieﬂy, 1 µg	total	RNA in	6 µl	water	was	incubated	with	1 µl	Annealing	Buffer	and	1 µl
oligo-dTs	(50mM) for	5min	at	65°C followed	by	an	incubation	on	ice	for	one	minute.






Biosystem). 3.52 µl	of	the	cDNA reaction	were	mixed	with	4.4 µl	of	forward	(1:20)
and	4.4 µl	of	reverse	primers	(1:20), 19.6 µl	water, and	35.04 µl	SYBR®	Green	PCR
Master	Mix. This	reaction	was	split	in	three	20 µl	aliquots	which	were	pipetted	in
a	96	well	plate	to	obtain	three	technical	replicates. Primers	used	for	qRT-PCR are
listed	in	table 7, and	cycling	conditions	were	as	follows: 2min	at	95°C,	10min	at
35
95°C,	followed	by	40	cycles	of	15 s	at	95°C and	60 s	at	60°C.	Relative	levels	of	gene
expression	were	quantiﬁed, using	the	2-∆∆CT equation. Melting	curve	analysis	was
carried	out	at	the	end	of	each	run	to	check	for	non-speciﬁc	ampliﬁcation.














Suspensions	were	incubated	on	a	rotating	wheel	at	4 °C for	10	to	20	minutes, ho-
mogenized	using	a	syringe	with	a	27G needle, and	then	centrifuged	at	12000 rpm,




Protein	 lysates	were	prepared	 as	 described	 above	 and	used	 immediately	 for	 im-
munoprecipitation. One	tenth	to	one-twentieth	of	each	supernatant	was	saved	(‘in-
put’)	while	the	remaining	sample	was	brought	to	a	volume	of	600 µl	by	adding	lysis
buffer	(without	DTT and	protease	inhibitor). Then	3 µl	of	an	80mg/ml	bovine	serum
albumin	solution	and	and	30 µl	Protein	A/G PLUS-Agarose	beads	were	added	to-
gether	with	the	appropriate	amount	of	desired	antibody, followed	by	incubation	on
a	rotating	wheel	at	4 °C overnight. The	next	day, samples	were	washed	5	times	with





































yet. In	adult	brain, the	only	evidence	comes	from	a	paper	published	by	Poulin	et al.
[65] where, alongside	various	other	tissues, brain	lysate	was	used	in	a	quantitative






that	speciﬁcally	detect	 the	 full	 length	canonical	 isoform	of	ANKHD1	and	do	not






ventral	forebrain, i.e. the	ganglionic	eminences	at	robust	levels	(Figure 6C).
We	further	investigated	mRNA expression	in	the	developing	forebrain	by	performing
in	situ hybridization	on	saggital	cryomicrotome	cut	sections	of	selected	embryonic
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Figure 6: ANKHD1 mRNA is expressed throughout neocortical development. A | Schematic repre-
sentation of the ANKHD1 gene structure in its genomic locus and positioning of primers for quantita-
tive real time PCR. The last three exons of ANKHD1 (32-34), the intermediate exon 0, and the ﬁrst two
exons of the downstream gene 4E-BP3 are shown on top. Beneath, mRNA transcripts of ANKHD1
and the fusion protein ANKHD1-BP3 are displayed. Red arrows indicate position of primers used
for detection of ANKHD1. B | mRNA was prepared from dorsal telencephalic cortices from indicated
embryonic stages (E12.5 - E17.5) and tested for ANKHD1 expression with above mentioned primers.
Expression values are normalized to the E12.5 data point. C | ANKHD1 mRNA expression in dorsal
telencephalic cortices and ganglionic eminences from E14.5 embryos was compared by quantitative
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32 33 34 0 A Bexon:
4EBP3 locusAnkhd1 locus
Figure 7: ANKHD1 mRNA expression assessed by in
situ hybridization. A | Schematic illustration of
RNA probe position for ANKHD1 detection by in situ hybridization. The probe was designed to span
over two exons and include exon 34, which is unique to ANKHD1 (compare with Figure 6). B | 15
µm saggital cryo-cut sections of E13.5. heads were prepared and subjected to in situ hybridization.
Scale bar= 20 µm. C | Higher magniﬁcation of neocortex from images shown in B. Scale bar= 100 µm.
















E12.5    E13.5    E14.5    E15.5   E16.5  E17.5   aNSCs
- 40 kDa
- 300 kDa
Figure 8: ANKHD1 protein is expressed in embryonic and adult neural progenitor cells. Protein
lysates were prepared from either dorsal telencephalic cortices at the indicated embryonic day (E12.5-
E17.5), or from short term cultured adult neural progenitor cells. Western blots were tested with












age of animal (months)
Figure 9: ANKHD1 is expressed in aNPCs throughout life. Total RNA was isolated from dissected
dentate gyri from Bl6 mice of different age (3 to 15 months). Samples were subjected to quantita-
tive real-time PCR with ANKHD1 primers. Data were normalized to beta-Actin expression and are






















tions	as	neurospheres, only	very	few	cells	will	be	able	to	differentiate. However, af-
ter	withdrawal	of	EGF and	FGF growth	factors, cells	differentiate	and	express	markers
of	post	mitotic	neurons	(such	as -III-tubulin). Cultured	NPCs	were	transfected	with
either	ANKHD1	or	non-targeting	siRNA and	grown	under	differentiating	conditions
for	six	days. As	seen	in	Figure 11, the	amount	of -III-tubulin	positive	cells	amongst
all	transfected	cells	was	decreased	when	ANKHD1	was	knocked	down. Conversely,
the	proportion	of -III-tubulin	positive	cells	increased	when	human	ANKHD1	was






















































B C D **
Figure 10: ANKHD1 knockdown promotes proliferation of aNPCs in
vitro. Low passage aNPCs
were electroporated with a YFP plasmid and siRNA targeted against ANKHD1 (KD) or non-targeting
control siRNA (NT). 48 hours later cells were treated with 10 µM EdU for 30 (B) or 45 (C) minutes
followed by immuno ﬂuorescence staining and EdU detection. A | Representative ﬂow cytometry dot
plots and gating strategy shown for a control sample. First the living cell population was selected and
doublets excluded, followed by gating on YFP positive cells and subsequently EdU positive cells.
Number of EdU positive cells amongst all YFP positive cells was measured. B | Percentage of EdU+
cells amongst all YFP+ cells after 30 minutes of EdU treatment. C | Percentage of EdU+ cells amongst
all YFP+ cells after 45 minutes of EdU treatment. D | Relative increase in number of of EdU+ cells of




brain	has	not	been	studied	yet. In	 fact, it	has	not	been	studied	 in	any	other	 tis-




























neuronal marker expression (ßIII tubulin)
Figure 11: ANKHD1 promotes diﬀerentiation of aNPCs in
vitro. Low passage aNPCs were elec-
troporated with a YFP plasmid and siRNA targeted against ANKHD1 (knockdown) or non-targeting
control siRNA (control), or with pCAG-YFP-ANKHD1. Six days later cells were stained with GFP and
-III-tubulin antibodies and analyzed by ﬂow cytometry.
for	photoreceptor	progenitor	proliferation	and	differentiation	during	development.
Moreover	some	MASK mutants	are	embryonic	lethal	[84]. Based	on	our	expression





Despite	the	lack	of	knockout	mice, eNPC function	can	be	studied in	vivo by	uti-
lizing	the in	utero electroporation	technique	to	speciﬁcally	target	radial	glia	cells:





shown	in	Figure 12A and	B,	respectively. Strikingly, the	number	of	progenitor	cells
that	incorporated	EdU was	markedly	increased	from	5.6%	±	0.2	to	12.4%	±	0.45







obtained	 in	other	publications. Due	to	 lack	of	suitable	antibodies	we	conﬁrmed
knockdown	of	ANKHD1	in	electroporated	brains	by	qRT-PCR.	Tissue	around	elec-
troporated	area	was	dissected	48	hours	post	IUE and	sorted	 for	YFP positive	cells
(3–4	embryos	were	pooled	 for	each	sample). Total	RNA was	 isolated	and	 tested







To	gain	 further	 insight	 into	 the	expanding	progenitor	pool, we	next	performed in
utero electroporation	of	E14.5	embryos	followed	by	immuno	ﬂuorescencestaining
of	 sections	 for	 the	 basal	 progenitor	marker	Tbr2	 and	 the	 neuronal	marker	 Satb2
(Figure 13A).	By	using	marker	expression	and	location	information	(see	Figure 13 E),
radial	glia, basal	progenitors, and	post-mitotic	neurons	can	be	distinguished. In-
















































































































Figure 12: ANKHD1 knockdown promotes eNPC proliferation in
vivo. A | Schematic illustration of
in utero electroporation and subsequent analysis. B | Representative ﬂow cytometry dot plots and
gating strategy of a control (upper row) and ANKHD1 knockdown (lower row) sample. First the living
cell population was selected and doublets excluded, followed by gating on YFP positive cells and
subsequently EdU positive cells. Number of EdU positive cells amongst all YFP positive cells was
measured. C | E13.5 embryos were electroporated with either pCAG-YFP and non-targeting siRNA
(CO) or pCAG-YFP and siRNA against ANKHD1 (KD). Dams were injected i.p. with 1 mg EdU 45
hours later and sacriﬁced 3 hours after EdU injections. n=4 for CO and 2 for KD from two litters. Data
are presented as mean and individual values, ***p<0.001, unpaired Student’s t-test. D | Same as in
C, but here E14.5 embryos were electroporated. n=5 for CO and 6 for KD, from two litters. Data
are presented as mean and individual values, **p<0.01, unpaired Student’s t-test. E | Knockdown of
ANKHD1 was conﬁrmed by qRT-PCR. Embryos were electroporated as in C and D. 48 hours later
tissue around electroporated area was isolated and sorted for YFP positive cells. Total RNA was
isolated from these cells and tested for ANKHD1 expression. n=2 (3–4 embryos pooled per sample).














































































phenotype   marker    location
radial glia (RG)   Pax6+, Tbr2-, Satb2-  ventricular zone, subventricular zone
basal progenitor (BP) Pax6+, Tbr2+, Satb2-  subventricular zone















Figure 13: ANKHD1 knockdown promotes apical and basal progenitor proliferation in
vivo. A |
Representative images of E16.5 neocortex sections 48 hours after in utero electroporation. Control
(upper panels) and ANKHD1 knockdown samples (lower panels) were stained for YFP (middle-left
panels), and Tbr2 (middle-right panels). Merged images are shown in panels on the right and nuclei
were counter-stained with Hoechst (left panels). VZ= ventricular zone, SVZ=subventricular zone,
IZ=intermediate zone, CP=cortical plate, V=ventral, M=medial. Scale bar=50 µm. B-D | Percentage
of radial glia cells (B), basal progenitor cells (C), and neurons (D) amongst all transfected cells in
embryos electroporated with non-targeting siRNA (CO) or siRNA against ANKHD1 (KD). n=5 embryos
for CO and n=6 embryos for KD from four different litters; total number of cells counted: n=1007 for
CO and n=1010 for KD. **p<0.01, ***p<0.001, two-way ANOVA. E | Discrimination of RG, BPs, and
neurons is based on marker expression and location.
48














Overexpression	of	 human	ANKHD1	 led	 to	 converse	 effects	 compared	 to	 knock-






















































Figure 14: ANKHD1 overexpression promotes diﬀerentiation in
 vivo. Representative images of
E16.5 neocortex sections 48 hours after in utero electroporation. Control (YFP, upper row), ANKHD1
overexpression (YFP-hANKHD1, middle row) and c-terminal truncated ANKHD1 overexpression
(Flag-ANKHD1-∆C, lower row) were stained for GFP or Flag (middle-left panels) and -III-tubulin
(middle-right panels). Merged images are shown in panels on the right; nuclei were counter stained
with Hoechst (left panels). VZ= ventricular zone, SVZ=subventricular zone, IZ=intermediate zone,
CP=cortical plate, V=ventral, L=lateral, M=medial. Scale bar=50 µm.
We	ﬁrst	analyzed	the	mouse	ANKHD1	for	a	nuclear	localization	and	nuclear	ex-
port	signal	(NLS and	NES,	resp.).Using	the	protein	predict	platform	[71], a	stretch
































































































Figure 15: Overexpression of human ANKHD1 rescues knockdown phenotype. A | Representative
images of E16.5 coronal neocortex sections 48 hours after in utero electroporation. Control (upper
panels) and ANKHD1 knockdown samples (lower panels) were stained for YFP (middle-left panel), and
Tbr2 (middle-right panel). Merged images are shown in panels on the right and nuclei were counter
stained with Hoechst (left panels). VZ= ventricular zone, SVZ=subventricular zone, IZ=intermediate
zone, CP=cortical plate, D=dorsal, M=medial. Scale bar=50 µm. B-D | Percentage of radial glia cells
(B), basal progenitor cells (C), and neurons (D) amongst all transfected cells in samples electroporated
with non-targeting siRNA (CO), siRNA against ANKHD1 (KD), or siRNA against ANKHD1 together with
pCAG-YFP-hANKHD1 (RE). n=2 embryos from two different litters; total number of cells counted:
n=482 for CO, n=621 for KD, and n=481 for RE, *p<0.05, two-way ANOVA.
51
on	tissue	sections. Notably, when	we	overexpressed	YFP tagged	ANKHD1	in	eNPCs
in	vivo, we	observed	it	mainly	in	the	cytoplasm, but	also	in	the	nucleus, similar	to
the	fractionation	experiments. Both	Sansores-Garcia	et al. [74] and	Sidor	et al. [81]
showed	that	ANKHD1	can	interact	with	YAP,	and	Sidor	et al. [81] suggested	that




interacts	with	YAP in	eNPC by	isolating	E13.5. dorsal	telencephalic	cortices	and
performing	co-immunoprecipitation	experiments. So	far, we	were	not	able	to	de-





























Homo spapiens        1413 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQEEDEENKPKENSELPEDEDEE 1492
Mus musculus         1416 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQE-DEENKPKENSEQPEGEDEE 1494
Rattus norvegicus    1405 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQE-DEENKPKVNSEQPEGEDEE 1483
Gallus gallus        1399 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQEEDEENKPKETLELHEDDDEE 1478
Mesocricetus auratus 1398 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQE-DEENKPKENSEQPEGEDEE 1476
Sus scrofa           1408 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQEEDEENKPKENSELPEDEDEE 1487
Bos taurus           1408 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQEEDEENKPKENSELPEDEDEE 1487
Canis familiaris     1408 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQEEDEENKPKENSELPEDEDEE 1487
Danio rerio          1407 LEKSREESKKQALAAKREKRKEKRKKKKEEQKRKLE-EEEAKVKEVSFEMLDQKED 1485
Equus caballus       1408 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQEEDEENKPKENSELPEDEDEE 1487
Pan paniscus         1411 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQEEDEENKPKENLELPEDEDEE 1490
Xenopus tropicalis   1375 LEKSREESRKQALAAKREKRKEKRKKKKEEQKKKLGDDEDSKILEIFDL---QDEE 1451
Macaca fascicularis  1428 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQEEDEENKPKENSELPEDEDEE 1507
Macaca mulatta       1377 LEKSREESRKQALAAKREKRKEKRKKKKEEQKRKQEEDEENKPKENSELPEDEDEE 1456
A
B
C C     M    N    N+   P
WB: Ankhd1
WB: GAPDH
Ankhd1   ASILLKELDLEKSREESRKQALAAKRE 1454
Ankrd17  ASILLEELDLEKLREESRRLALAAKRE 1482
         *****:****** *****: *******
Ankhd1  KRKEKRKKKKEEQKRKQEEDEENKPKEN 1514
Ankrd17 KRKEKRRKKKEEQRRKLEEIE-AKNKEN 1541
        ******:******:** ** *  * ***
D E YFP-Ankhd1
Figure 16: ANKHD1 contains a putative NLS and can localize to the nucleus. A | Putative nuclear
localization signal (NLS) in human ANKHD1. NLS highlighted as identiﬁed by prediction with preditpro-
tein.org [71] and ELM [20]. B | Protein sequence alignment of ANKHD1 from various species. Aligned
with COBALT. Accession numbers of shown species: Homo sapiens (NP_060217.1), Mus musculus
(NP_780584.2), Rattus norvegicus (NP_001190982.1), Gallus gallus (NP_001191026.1), Mesocrice-
tus auratus (XP_005069288.1), Sus scrofa (NP_001190196.1), Bos taurus (XP_005209554.1), Ca-
nis familiaris (NP_001191024.1), Danio rerio (NP_001186697.1), Equus caballus (NP_001191034.1),
Pan paniscus (XP_003829227.1), Xenopus tropicalis (NP_001191021.1), Macaca fascicularis
(XP_005558028.1), Macaca mulatta (XP_002804593.1). C | Alignment of human ANKHD1 and
its paralog Ankrd17 with Clustal Omega, accession numbers: ANKHD1, see above, Ankrd17:
NP_115593.3. D | Western Blot of sub-cellular fractions of aNPCs. C = cytoplasmic extract, M =
membrane extract, N = nuclear extract, N+ = chromatin-bound extract, P = pellet extract. E | pCAG-
YFP-ANKHD1 was overexpressed via in utero electroporation in E14.5 neocortex. Cryomicrotome
sections were prepared 48 hours later and stained with GFP antibody.
53
WB: SHP2















Figure 17: ANKHD1 does not interact with SHP2. Dorsal cortices of E13.5 embryos were dissected,
followed by cell lysis and immunoprecipitation with either ANKHD1 antibody (lane 4), SHP2 antibody
(lane 3), or an isotope control antibody (lane 2). 5% of total cell lysate were kept as input sample (lane








First, we	 tested	ANKHD1	expression	 in	 various	GIC cultures	 (we	 received	GBM
samples	from	two	different	hospitals	and	denote	them	GBM or	NMA,	depending	on





with	siRNA designed	against	ANKHD1(see	Figure 23). The	ratio	of	the	canonical
isoform	to	smaller	products	did	vary	from	sample	to	sample	but	was	usually	stable
for	a	given	GIC culture	over	time. Notably, very	little	full	length	ANKHD1	was	de-





identity; they	might, however, represent	the	ANKHD1-BP3	fusion	protein	described















Figure 18: ANKHD1 expression in GBM Various GIC cultures were tested for ANKHD1 expression.
Total lysates were prepared and tested with antibodies against ANKHD1 (upper panels) or beta-Actin
(lower panels). All ﬁve bands in upper levels detect ANKHD1: the largest is representing the canonical
isoform, while the others are other isoforms or break down products. The very large band in GBM





GIC cultures	(GBM 13	and	30)	for	following	experiments. Cells	were	transfected	by
electroporation, either	with	siRNA targeting	human	ANKHD1	together	with	a	pCAG-
YFP plasmid, non-targeting	siRNA with	pCAG-YFP,	or	a	YFP-ANKHD1	plasmid	un-
der	the	control	of	a	CAG promoter. Knockdown	and	overexpression	were	checked
by	quantitative	real-time	PCR (see	Figure 20B and	D) and	also	conﬁrmed	by	Western
blotting	(see	Figure 23 for	an	example). To	determine	the	effect	of	ANKHD1	knock-
down	or	overexpression	on	GIC proliferation, EdU incorporation	was	measured	by
ﬂow	cytometry	72	hours	after	electroporation. Flow	cytometry	dot	plots	and	gating
strategies	for	representative	samples	are	shown	in	Figure 19. Interestingly, other	then
in	murine	NPCs, knockdown	of	ANKHD1	did	not	have	an	effect	on	GIC prolifera-
tion	in	any	of	the	two	cultures	tested	(Figure 20A and	C;	GBM13: control	=	10.90%
±	0.70, knockdown	=	13.35%	±	1.55; GBM30: control	=	6.72%±	2.02, knockdown













pression	levels	(Figure 21, fourth	lane). These	data	suggest	ANKHD1	is	able	to	mod-
ulate	p21	expression, which, in	turn, may	contribute	to	the	proliferation	effects	de-
scribed	above.
3.5.4 Akt	and	Erk	activation	is	not	inﬂuenced	by	ANKHD1	levels
Tumor	cells	often	exhibit	 aberrant	 signaling	 in	pathways	 involved	 in	growth	and









used. Next, we	 tested	 if	ANKHD1	can	 interfere	with	CD95	promoted	activation
of	Akt	or	inhibition	of	Erk, and	if	ANKHD1	by	itself	had	any	effect	on	Akt	or	Erk
phosphorylation. To	this	end, GBM13	or	GBM30	cells	were	ﬁrst	electroporated



























A GBM 13: control sample



























C GBM 13: overexpression
D GBM 30: control sample




















































Figure 19: Flow cytometry dot plots and gating strategy of GIC samples tested for EdU incorpo-
ration. A | GBM 13 cells electroporated with non-targeting siRNA and pCAG-YFP were ﬁrst broadly
gated for living cells (left panel), followed by doublet exclusion (middle left panel), and exclusion of
sub-G1 DNA content events (not shown). Finally YFP positive (middle right panel) and EdU positive
(right panel) cells were identiﬁed. YFP and EdU gates were set against negative controls. B | YFP (left
panel) and EdU (right panel) positive populations in GBM13 cells electroporated with siRNA against
ANKHD1 and pCAG-YFP. C | YFP (left panel) and EdU (right panel) positive populations in GBM13





















































GBM30: EdU incorporationGBM13: qPCR GBM30: qPCR
** **
Figure 20: ANKHD1 overexpression promotes GIC proliferation in
 vitro. A+C | GBM 13 (A) or
GBM 30 (C) cells were electroporated with either pCAG-YFP together with non-targeting siRNA (CO),
pCAG-YFP together with siRNA targeting ANKHD1 (KD), or pCAG-YFP-ANKHD1 (OE). 72h later cells
were treated with 20µM EdU for 60 minutes, followed by ﬁxation and staining for EdU, YFP and DNA
content. EdU incorporation amongst YFP positive cells was measured by ﬂow cytometry as de-
scribed in Fig. 19. Data are presented as mean ± s.d., n=2, one-way ANOVA, **p < 0.01. B+D |
Knockdown and overexpression of ANKHD1 was conﬁrmed by qRT-PCR.
WB: p21 - 21 kDa
WB: GAPDH - 42 kDa





Figure 21: ANKHD1 regulates p21 expression levels in GBM 13. GBM 13 cells were either left
untreated, or electroporated with pCAG-YFP together with non-targeting siRNA (NT), pCAG-YFP
together with siRNA targeting ANKHD1 (KD), or pCAG-YFP-ANKHD1 (OE). 72h later cells were har-
vested and lysed, followed by Western blotting for GAPDH (loading control, upper lane), and p21
(lower lane). Changes of p21 expression levels in lanes 2 - 4 relative to untreated cells (lane 1) are




and	tErk, resp.). Contrary	to	previous	reports, Akt	activation	was	not	observed	in
GBM13	or	GBM30	cells	following	stimulation	with	10 ng/ml	T4	 (Figure 23A and
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GBM 13GBM 30
10ng/ml T4 40ng/ml T4
Figure 22: ANKHD1 expression levels are not inﬂuenced by CD95 activation in GICs. GBM 13 and
30 cells were left untreated (UT), or were treated with 10 ng/ml (left panel) or 40 ng/ml (right panel)
T4 for 24 or 48 hours before preparation of cell lysates and Western blotting. Membranes were then
tested with the indicated antibodies.
Together, the	presented	data	suggest	that	ANKHD1	is	highly	expressed	in	most	of
the	tested	GIC cultures	and	that	high	ANKHD1	levels	might	contribute	to	the	cells’
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Figure 23: Akt and Erk activity is not inﬂuenced by ANKHD1 knockdown. A | GBM 13 (A) or GBM
30 (B) cells were electroporated with pCAG-YFP together with non-targeting siRNA (CO), or pCAG-
YFP together with siRNA targeting ANKHD1 (KD). 72h later cells were treated with 10 ng/ml T4 for
15 or 30 minutes, or left untreated (UT), followed by cell lysis and Western blotting. Membranes were
tested with the indicated antibodies. B | Same as in A, but with 40 ng/ml T4 treatment and including




functions	–	such	as	reasoning, planning, emotions, and	problem	solving	–	which
are	so	central	 to	what	we	are. The	main	structure	 involved	 in	 these	 functions	 is
the	neocortex. It	 is	 part	 of	 the	dorsal	 forebrain	which	underwent	 a	 tremendous





















































by	Poulin	et al. [65] in	2003. The	authors	described	ANKHD1	mRNA levels	deter-
mined	by	qRT-PCR in	 the	brain, eye, spleen, lung, liver, smooth	muscle, kidney,

















cells. A role	of	ANKHD1	seems	to	be	in	proliferation	control, and	if	it	is	expressed
in	post	mitotic	cells	as	well	it	would	be	intriguing	to	study	if	in	these	cells	ANKHD1
is	involved	in	maintaining	a	non-proliferative	state	or	has	different	functions.
Poulin	et al. [65] also	studied	ANKHD1	expression	by	Northern	blotting	in	human
tissues, including	heart, brain, placenta, skeletal	muscle, and	pancreas. They	found
no, or	only	very	little	expression	of	ANKHD1	in	the	brain. However, it	is	not	clear





limitations	 to	this	dataset: (i)	 these	data	were	not	validated, and	(ii)	 the	antibody












developing	mammalian	brain. We	have	used	qRT-PCR, in	situ hybridization, and











that	it	is	expressed	in	eNPCs. We	next	performed in	situ hybridization	experiments
to	analyze	ANKHD1	in	more	detail. We	found	broad	expression	of	ANKHD1	at










have	been	conducted. Smith	et al. [84] showed	that	MASK is	essential	for	early	em-
bryogenesis, since	most	MASK loss-of-function	mutants	are	embryonic	lethal, and
that	 it	 is	 later	required	for	normal	proliferation	and	differentiation	of	photorecep-











ing	mammalian	brain in	vivo, we	used	the in	utero electroporation	technique. With
this	technique	it	is	possible	to	speciﬁcally	manipulate	RG cells	in	the	developing





daughter	cells	of	RG.	 Importantly, not	all	cells	 in	 the	electroporated	area	will	be
transfected	and	thus	the	study	of	cell	extrinsic	effects	might	be	limited. Compared
to	knockout	mice, in	utero electroporation	has	several	advantages	(e.g. it	allows	to
overcome	compensatory	mechanisms	of	gene	redundancy, different	brain	regions
can	be	targeted, combinatorial	knockdown	of	two	or	more	genes	may	be	easily	per-
formed, etc.) but	also	a	few	disadvantages	(e.g. the	special	equipment	required,






which	did	not	show	obvious	phenotypes	in	this	case. The in	utero electroporation
method	is	often	utilized	in	studies	of	mammalian	brain	development	and	has	proven
to	be	 reliable, despite	of	 some	cases	 in	which	conﬂicting	 results	were	produced
compared	to	knockout	mice	[67].
First, we	wanted	to	investigate	the	effects	of	ANKHD1	knockdown	on	developing










cells	on	cryosections	with	markers	 for	RG,	BPs, and	neurons. The	proportion	of
both, RG and	BPs	was	 increased, while	 the	number	of	newly	born	neurons	was
decreased	 in	ANKHD1	knockdown	cells. These	data	suggest	 that	knockdown	of
ANKHD1	promotes	proliferation	and	inhibits	differentiation	to	neurons. In	Droso-
phila	photoreceptor	progenitors, loss	of	MASK similarly	leads	to	a	lower	number	of
differentiated	cells. However, the	authors	did	not	observe	more	proliferation, they
rather	suggested	that	apoptosis	is	increased. Sansores-Garcia	et al. [74] and	Sidor
et al. [81] demonstrated	that	loss	of	mask	leads	to	smaller	organs. This	suggests	that
loss	of	ANKHD1	would	rather	promote	differentiation	than	inhibiting	it, generating
insufﬁcient	numbers	of	differentiated	cells. However, it	 is	also	possible	that	cells
without	ANKHD1	initially	 fail	 to	differentiate	and	 thus	are	kept	 in	a	proliferative

















that	both	RG and	BP pools	were	expanded. We	used	expression	of	the	transcrip-
tion	factor	Tbr2	to	distinguish	RG from	BP cells. Tbr2	was	shown	to	be	exclusively
expressed	in	BPs	[23], and	hitherto	remains	the	only	reliable	marker	to	distinguish
BP from	RG,	beside	 some	morphological	 characteristics. Interestingly, the	num-








the	increase	in	RG cells. As	mentioned	above, this	effect	can	be	explained	in	part




was	knocked	down. A shift	of	asymmetric	RG division	from	neurons	to	BPs	is	most
likely	not	sufﬁcient	to	explain	the	decrease	in	neurons. Especially	because	at	this
time	of	development, the	main	neurogenic	phase, most	RG division	already	produce
BPs, and	RG to	neuron	division	are	less	frequent. A change	in	RG differentiation







Apart	from	RG and	BP cells, some	other	progenitor	cell	types	have	been	described
(see	introduction). However, these	cells	are	not	very	abundant, poorly	studied	and
molecular	markers	for	 their	 identiﬁcation	are	lacking. Hence, we	did	not	further




utero electroporation. Apart	from	a	complete	blockade	of	differentiation, it	might	be





























formed in	vitro proliferation	and	differentiation	assays. We	used	aNPCs	 isolated
from	the	SVZ of	adult	mice	which	were	then	cultured	in	serum	free	media	as	neu-
roshperes. Cells	isolated	and	cultured	this	way	were	shown	to	retain	aNPC charac-




as	in	eNPCs. Moreover, knockdown	of	ANKHD1	in	an	aNPC differentiation	assay
caused	 fewer	neurons	 to	 form. Conversely, overexpression	of	ANKHD1	 resulted
in	more	differentiated	neurons. These	data	suggest	that	ANKHD1	might	have	con-
served	functions	in	aNPCs. However, in	vivo experiments	will	be	needed	to	fully
understand	the	role	of	ANKHD1	in	aNPCs. For	instance, virus	mediated	knockdown
of	ANKHD1	in	aNPCs	of	the	SVZ could	be	utilized	to	verify	proliferation	and	differ-






RG cells	during	embryonic	development. However, due	to	the	very	different	envi-
ronment	that	aNPCs	face, also	additional	and	/	or	alternative	functions	for	proteins
known	from	development	have	been	described. For	instance, Wnt	signaling	Exam-
ples? at	least	refs. Future	work in	vivo will	shed	more	light	into	the	functions	of
ANKHD1	in	the	adult	brain.
4.5 Involvement	of	ANKHD1	in	GBM

























these	cells	 suggest	 that	 it	 is	 indeed	a	population	capable	of	 tumor	 initiation	and
sustainable	tumor	growth.
We	used	these	GICs	to	gain	ﬁrst	insights	into	the	role	of	ANKHD1	in	GBM.	First,
we	examined	ANKHD1	expression	in	various	GIC samples. Indeed, ANKHD1	was
expressed	in	all	GIC samples	tested. Levels	of	expression	varied	signiﬁcantly	be-
tween	 samples, and	 tended	 to	 increase	with	passages	of	 cultures	 (not	quantiﬁed
observations). All	expression	levels	measured	were	higher	compared	to	a	human











mRNA levels	 in	multiple	myeloma	[19]. Notably, all	of	 the	establishes	 leukemia
cell	 lines	Traina	et al. [92] and	Dhyani	et al. [19] tested	showed	strong	ANKHD1
expression	by	Western	blotting. We	have	also	observed	ANKHD1	to	be	highly	ex-
pressed	in	established	cancer	cell	lines, including	K562	and	HEK 293	cells. It	is	not
clear	if	this	high	levels	on	cancer	cell	lines	are	related	to	the	fact	that	the	cells	are
of	a	cancerous	origin, or	rather	have	to	do	with	culturing	conditions	and	cell	cell




Functional	roles	of	ANKHD1	in	tumors	are	poorly	studied. Dhyani	et al. [19] have
shown	that	knockdown	of	ANKHD1	in	multiple	myeloma	cells	inhibited	their	pro-
liferation	and	G1	to	S phase	transition	of	 the	cell	cycle. In	NPCs, we	found	that
knockdown	of	ANKHD1	rather	leads	to	higher	proliferation	rates	and	that	overex-
pression	favors	differentiation	of	cells. Therefore	it	was	of	interest	to	test	the	inﬂuence
of	ANKHD1	on	proliferation	of	GBM cells. Surprisingly, proliferation	was	increased
signiﬁcantly	when	we	overexpressed	ANKHD1	in	GICs. We	did	not	observe	sig-














Together, our	ﬁndings	support	 that	ANKHD1	might	be	highly	expressed	 in	many
GBM cells	and	promote	their	proliferation, similar	to	its	function	in	leukemia	cells.





















et al. [101] have	shown	that	all	ﬁve	isoforms	of	E2F activate	hTERT transcription	in
normal	human	somatic	cells. In	tumor	cells, however, E2F–1	to	3	(but	not	4	and	5)




tein	binding	via	 the	ankyrin	 repeats	or	RNA binding	via	 the	KH domain	are	dif-

















not	co-immunoprecipitate	(co-IP) the	two	proteins	in	NPC lysates. Either	the	co-IP
in	NPCs	is	technically	not	feasible	with	endogenous	proteins, or	they	simply	do	not
interact	in	these	cells. Notably, we	also	failed	to	repeat	the	co-IP published	in	K562
cells. Co-IP with	one	of	the	proteins	overexpressed	and	tagged	might	provide	further
insight, but	will	not	prove	the	interaction	of	endogenous	proteins.








YAP and	ANKHD1	in	eNPCs. Currently, the	interaction	with	TAZ is	being	probed.










still	might	be	 functional	 relevant. Indeed, Sidor	et al. [81] were	able	 to	 identify
ANKHD1	in	a	DNA pulldown	experiment	with	a	sequence	of	the	YAP target	gene
diap1. However, Sansores-Garcia	et al. [74], who	all	investigated	the	ANKHD1	-
YAP interaction, did	not	observe	a	YAP dependent	recruitment	of	ANKHD1	to	the
nucleus	or	 its	presence	in	complexes	binding	 to	DNA.	Thus	 the	signiﬁcance	and
function	of	ANKHD1	in	the	nucleus	remains	elusive	and	has	to	further	investigated
in	the	future.
Dhyani	et al. [19] suggested	that	ANKHD1	might	control	cell	cycle	progression	by
regulating	expression	levels	of	the	cyclin	dependent	kinase	inhibitor	p21. It	inhibits
the	activity	of	cyclin	dependent	kinase	(CDK) 1, -CDK2, and	CDK4/6	complexes
thus	 regulating	 cell	 cycle	progression	at	G1	and	S phase. P21	mediates	 growth
arrest	and	cell	senescence. We	observed	that	knockdown	of	ANKHD1	increased
levels	of	p21	protein	 in	GIC cultures, while	overexpression	slightly	decreased	 its
levels. This	effect	is	similar	to	that	reported	in	multiple	myeloma	cells	by	Dhyani
et al. [19]. However, the	measured	change	is	also	quite	small	and	it	is	unclear	if	it
is	sufﬁcient	to	be	solely	responsible	for	the	observed	effects	on	cell	proliferation.
Important	signaling	components	of	survival	and	proliferation	in	GBM include	Akt











ANKHD1	also	contains	a	type I KH domain	that	can	bind	single	stranded	DNA or
RNA (see 1.5). Indeed, experimental	evidence	suggests	that	ANKHD1	is	a	RNA bind-
ing	protein: Castello	et al. [12] reported	ANKHD1	as	a	mRNA binding	protein	iden-
tiﬁed	in	a	mRNA interactome	screen	([13]). Hitherto, it	is	unknown	which	mRNAs
and	possible	other	RNA species	are	bound	by	ANKHD1, or	if	its	function	in	NPCs	is
based	on	its	RNA binding	ability. We	have	cloned	a	mutated	form	of	ANKHD1	that
lacks	the	KH domain	(ANKHD1-KH).	Unlike in	utero overexpression	of	full	length
ANKHD1, ANKHD1-KH seemingly	failed	to	promote	differentiation	of	developing
neocortical	neurons. More	detailed	work	is	needed	to	elucidate	the	function	of	the
KH domain	in	ANKHD1	during	NPC proliferation	and	differentiation. It	will	be	cru-
cial	to	identify	the	RNAs	bound	to	ANKHD1	via	cross-linking	immunoprecipitation


















differentiation	control, the	precise	 functions	 remain	 largely	elusive	and	might	be
75














additional	 to	 its	well	described	 function	 in	progenitor	cells, Notch	 is	also	essen-
tialIs	for	synaptic	plasticity	in	some	hippocampal	neurons	[1]. No	such	diverging









layer	grown	cells). A search	in	the	Human	Protein	Atlas	database	[91], revealed	that
45	out	of	the	47	testes	cell	lines	were	classiﬁed	as	having	a	strong	ANKHD1	expres-































synaptic	plasticity	in	hippocampal	networks. Neuron, 69(3):437–444, 2011.
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